Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

BUY
$4.88 - $8.56 $4.33 Million - $7.59 Million
886,601 Added 274.07%
1,210,100 $9.4 Million
Q4 2021

Feb 15, 2022

SELL
$7.03 - $13.03 $447,832 - $830,050
-63,703 Reduced 16.45%
323,499 $2.27 Million
Q3 2021

Nov 16, 2021

SELL
$11.11 - $17.84 $5.58 Million - $8.97 Million
-502,531 Reduced 56.48%
387,202 $4.37 Million
Q2 2021

Aug 16, 2021

BUY
$13.68 - $22.34 $2.05 Million - $3.35 Million
150,033 Added 20.28%
889,733 $16.1 Million
Q1 2021

May 18, 2021

BUY
$9.0 - $63.91 $2.94 Million - $20.9 Million
326,700 Added 79.1%
739,700 $16.8 Million
Q4 2020

Feb 17, 2021

BUY
$4.82 - $10.1 $358,126 - $750,430
74,300 Added 21.94%
413,000 $3.41 Million
Q3 2020

Nov 17, 2020

SELL
$4.7 - $8.7 $2.72 Million - $5.03 Million
-578,000 Reduced 63.05%
338,700 $1.64 Million
Q2 2020

Aug 17, 2020

BUY
$5.54 - $10.81 $861,470 - $1.68 Million
155,500 Added 20.43%
916,700 $6.52 Million
Q1 2020

May 15, 2020

BUY
$2.47 - $21.36 $1.28 Million - $11.1 Million
519,500 Added 214.94%
761,200 $5.24 Million
Q4 2019

Feb 14, 2020

BUY
$15.72 - $24.88 $2.3 Million - $3.64 Million
146,200 Added 153.09%
241,700 $4.14 Million
Q3 2019

Nov 14, 2019

BUY
$24.74 - $49.3 $155,862 - $310,590
6,300 Added 7.06%
95,500 $2.36 Million
Q2 2019

Aug 15, 2019

SELL
$34.66 - $63.73 $5.19 Million - $9.54 Million
-149,700 Reduced 62.66%
89,200 $4.15 Million
Q1 2019

May 16, 2019

BUY
$64.85 - $100.15 $265,885 - $410,615
4,100 Added 1.75%
238,900 $15.7 Million
Q4 2018

Feb 15, 2019

SELL
$65.89 - $165.64 $30.6 Million - $76.8 Million
-463,700 Reduced 66.39%
234,800 $16.6 Million
Q3 2018

Nov 14, 2018

BUY
$22.1 - $214.06 $15.4 Million - $150 Million
698,500 New
698,500 $100 Million

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $1.01B
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.